semaglutide type 1 diabetes automated insulin delivery randomized trial 2025 Weekly improves blood sugar and weight in adults with ADJUST-T1D Suggests Semaglutide Efficaciously Treats

Walmart and Amazon recently expanded employee access to these treatments through their health benefits

Despite being an older medication, its continued use reflects strong real-world effectiveness, especially for individuals who need short-term appetite control or a bridge between treatments

Short non-diabetic data support remaining at 2.5 mg when weight and insulin-resistance markers are already moving and tolerability favors a hold. The label still positions 2.5 mg as the starter before 5 mg, so it is a defensible low-dose floor for selected users rather than a replacement for the 5 mg obesity-trial floor

The presence of a vial and the need to reconstitute do not indicate that injection is the validated cosmetic route